What I think Covid-19 variants mean for the Rolls-Royce share price

Jay Yao writes how he thinks Covid-19 variants have affected the Rolls-Royce share price recently and how they might affect the shares in future.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Since early December, the Rolls-Royce (LSE:RR) share price is down almost 30%, wiping out some of the gains after the rally that began in October. The fall also means its 12-month decline is 60%+ when factoring in the rights issue’s effects.

Why has this happened just as vaccines seem to offer light at the end of the lockdown tunnel? I see the increasing spread of Covid-19 variants such as the South African and UK strains as a key factor. Some Covid-19 vaccines don’t work as well against the variants. There have been reports that the vaccine made by AstraZeneca isn’t as effective against moderate and mild cases of the South African strain. This has caused some concern among investors over how quick the travel sector’s recovery might be. 

The changing nature of Covid-19 variants could affect the Rolls-Royce share price going forward. After all, RR is very much a share dependent on what’s happening globally, rather than just a successful vaccine rollout in a few countries. But how much could Covid-19 variants affect the Rolls-Royce share price going forward?

Mutating virus

It’s impossible to fully vaccinate everyone against Covid-19 in a very short amount of time. So Covid-19 could always be around and will also very likely continuously mutate. Some mutated strains could spread fast — some commentators have already said the UK strain could become dominant globally.

There’s always the possibility that a mutation gets out of control again before new vaccines arrive. Such mutated strains could severely disrupt air travel’s recovery trajectory.

I think that makes the future of air travel-linked stocks hard to predict. Essentially, the threat of new variants means an airline can’t say that it will make X amount of money next year with as much certainty as before the pandemic. What might his mean for shareholders? I reckon companies might feel the need to have stronger balance sheets than pre-pandemic levels to prepare for any potential declines in travel ahead. That could mean lower capital returns in the near term.

And the Rolls-Royce share price?

Because Rolls-Royce sells jet engines to airlines and maintains them, variants also affect the company. If airlines try to beef up their balance sheets more to protect against potential variant effects, some might delay orders for new jet engines. This could mean a more-drawn-out recovery phase for Rolls-Royce’s civil aviation unit.

How the variants affect the Rolls-Royce share price going forward is unclear given the uncertain nature of mutations. On the upside, if the pandemic can be controlled globally by current vaccines and new vaccines developed quickly to deal with mutations, I see potential for the Rolls-Royce share price to rise.

I think the company’s civil aviation unit will recover, but could take a while to fully do so.

I’d still buy Rolls-Royce shares, however, given the company’s potential in green technologies. Rolls-Royce is a leader in aircraft engines and I think it could be a leader in electric aircraft engines and/or electric aircraft in the future too. This is an area its moving into. With aircraft such as electric air taxis potentially being more convenient than regular land vehicles in many cases, I reckon the market could be huge. If management makes the right decisions, I feel Rolls-Royce has a big growth opportunity ahead that could add a lot of value. 

Jay Yao has no position in any of the shares mentioned. The Motley Fool UK has recommended The New York Times. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Dividend-paying FTSE shares had a bumper 2025! What should we expect in 2026?

Mark Hartley identifies some of 2025's best dividend-focused FTSE shares and highlights where he thinks income investors should focus in…

Read more »

piggy bank, searching with binoculars
Dividend Shares

How long could it take to double the value of an ISA using dividend shares?

Jon Smith explains that increasing the value of an ISA over time doesn't depend on the amount invested, but rather…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

£5,000 invested in Tesco shares 5 years ago is now worth this much…

Tesco share price growth has been just part of the total profit picture, but can our biggest supermarket handle the…

Read more »

Investing Articles

Here’s why I’m bullish on the FTSE 100 for 2026

There's every chance the FTSE 100 will set new record highs next year. In this article, our Foolish author takes…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Growth Shares

UK interest rates fall again! Here’s why the Barclays share price could struggle

Jon Smith explains why the Bank of England's latest move today could spell trouble for the Barclays share price over…

Read more »

Man hanging in the balance over a log at seaside in Scotland
Investing Articles

2 out-of-favour FTSE 250 stocks set for a potential turnaround in 2026

These famous retail stocks from the FTSE 250 index have crashed in 2025. Here's why 2026 might turn out to…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Down over 30% this year, could these 3 UK shares bounce back in 2026?

Christopher Ruane digs into a trio of UK shares that have performed poorly this year in search of possible bargains…

Read more »

Mature people enjoying time together during road trip
Investing Articles

Yields up to 8.5%! Should I buy even more Legal & General, M&G and Phoenix shares?

Harvey Jones is getting a brilliant rate of dividend income from his Phoenix shares, and a surprising amount of capital…

Read more »